Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination

Since the first cases were discovered at the end of 2019, the ongoing coronavirus disease 2019 (COVID-19) pandemic has significantly changed the lives of people around the world. Vaccines to prevent infection from its causative organism, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were developed by the end of 2020 and have now become humanity's hope of regaining normalcy by acquiring protective immunity against COVID-19. However, as vaccines against COVID-19 have been distributed globally at an unprecedented rate, cases of serious adverse events post-vaccination have been accumulating.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research